Bioinorganic chemistry of anti-thyroid drugs: An unusual formation of a copper (II) complex

被引：10

作者：

Roy, Gouriprasanna ^{[1
]}

Nethaji, Munirathinam ^{[1
]}

Mugesh, G. ^{[1
]}

机构：

[1] Indian Inst Sci, Dept Inorgan & Phys Chem, Bangalore 560012, Karnataka, India

来源：

INORGANIC CHEMISTRY COMMUNICATIONS | 2006年 / 9卷 / 06期

关键词：

anti-thyroid drugs; copper complex; DFT calculations; lactoperoxidase inhibition activity; methimazole; selenium;

D O I：

10.1016/j.inoche.2006.02.018

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

We report the first example of a metal complex derived from the selenium analogue of the anti-thyroid drug methimazole (MSeI). The treatment of the diselenide form of Se-methimazole with copper (11) perchlorate leads to an unexpected deselenation reaction resulting in the formation of a novel copper (11) complex (7). Theoretical studies are performed on compounds 5 and 6 to understand the structural changes that take place at the imidazole moiety upon deselenation. In addition, glutathione peroxidase (GPx) behavior and lactoperoxidase (LPO) inhibition activities of complex 7 are described. (C) 2006 Elsevier B.V.. All rights reserved.

引用

页码：571 / 574

页数：4

共 50 条

[41] EFFECTS OF THYROID-HORMONES, ANTI-THYROID DRUGS AND IODIDE ON INVITRO CONVERSION OF THYROXINE TO TRIIODOTHYRONINE
AIZAWA, T
YAMADA, T
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (03) : 215 - 225
[42] THYROID SUPPRESSION TEST AND OUTCOME OF HYPER-THYROIDISM TREATED WITH ANTI-THYROID DRUGS AND TRIIODOTHYRONINE
YAMAMOTO, M
IGARASHI, T
KIMURA, S
TSUKAMOTO, S
TOGAWA, K
OGATA, E
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (01): : 72 - 77
[43] MECHANISM OF ACTION OF THIOUREYLENE ANTI-THYROID DRUGS IN THE RAT - POSSIBLE INACTIVATION OF THYROID PEROXIDASE BY PROPYLTHIOURACIL
SHIROOZU, A
TAUROG, A
ENGLER, H
DORRIS, ML
[J]. ENDOCRINOLOGY, 1983, 113 (01) : 362 - 370
[44] Side Effects of Anti-Thyroid Drugs and Their Impact on the Choice of Treatment for Thyrotoxicosis in Pregnancy
Taylor, Peter N.
Vaidya, Bijay
[J]. EUROPEAN THYROID JOURNAL, 2012, 1 (03) : 176 - 185
[45] AGRANULOCYTOSIS ASSOCIATED WITH ANTI-THYROID DRUGS - EFFECTS OF PATIENT AGE AND DRUG DOSE
COOPER, DS
GOLDMINZ, D
LEVIN, AA
LADENSON, PW
DANIELS, GH
MOLITCH, ME
RIDGWAY, EC
[J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) : 26 - 29
[46] Effect of thione—thiol tautomerism on the inhibition of lactoperoxidase by anti-thyroid drugs and their analogues
P. N. Jayaram
Gouriprasanna Roy
Govindasamy Mugesh
[J]. Journal of Chemical Sciences, 2008, 120
[47] Population-Based Studies of Anti-thyroid Drugs and Sudden Cardiac Death
van Noord, Charlotte
Sturkenboom, Miriam C. J. M.
Straus, Sabine M. J. M.
Hofman, Albert
Witteman, Jacqueline C. M.
Stricker, Bruno H. Ch.
[J]. DRUG SAFETY, 2009, 32 (10) : 956 - 957
[48] FURTHER-STUDIES OF ACTION OF ANTI-THYROID DRUGS ON MYCOBACTERIUM-LEPRAE
LEVY, L
ANANDAN, JA
[J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1978, 158 (04): : 582 - 585
[49] Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis
Oren, R
Maaravi, Y
Karmeli, F
Kenet, G
Zeidel, L
Hubert, A
Eliakim, R
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) : 341 - 345
[50] THE TREATMENT OF GRAVES-DISEASE WITH ANTI-THYROID DRUGS AND SMALL DOSES OF RADIOIODINE
JAFFIOL, C
BALDET, L
PAPACHRISTOU, C
LAVIT, C
MIROUZE, J
[J]. ANNALES D ENDOCRINOLOGIE, 1980, 41 (06) : 593 - 596

← 1 2 3 4 5 →